Odyssey Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Odyssey Therapeutics's estimated annual revenue is currently $38.4M per year.
- Odyssey Therapeutics's estimated revenue per employee is $193,750
Employee Data
- Odyssey Therapeutics has 198 Employees.
- Odyssey Therapeutics grew their employee count by -1% last year.
Odyssey Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and consultant | Reveal Email/Phone |
2 | Founder, President And CEO | Reveal Email/Phone |
3 | Chief Research Operations and Portfolio Strategy | Reveal Email/Phone |
4 | Chief Research Operations and Portfolio Strategy | Reveal Email/Phone |
5 | Chief Research Operations and Portfolio Strategy | Reveal Email/Phone |
6 | EVP | Reveal Email/Phone |
7 | EVP and Head Discovery | Reveal Email/Phone |
8 | VP, Oncology | Reveal Email/Phone |
9 | EVP | Reveal Email/Phone |
10 | VP, Biology | Reveal Email/Phone |
Odyssey Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Odyssey Therapeutics?
At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated drug hunting engine.
keywords:N/AN/A
Total Funding
198
Number of Employees
$38.4M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 198 | 3% | N/A |
#2 | $71.4M | 198 | -1% | N/A |
#3 | $15M | 198 | 1% | N/A |
#4 | $44.6M | 198 | 3% | N/A |
#5 | $57.7M | 198 | 21% | N/A |